Abstract:Background. A recognized non-invasive biomarker to improve risk stratification of IgA nephropathy (IgAN) patients is scarce. CXCL16 has been shown to play a key role in inflammatory disease as chemoattractant, adhesion and even fibrosis factor. The current study assessed possibility of plasma CXCL16 as a novel biomarker in IgAN patient.Methods. Plasma CXCL16 was measured in 230 patients with renal biopsy consistent IgAN from 2012 to 2014, and clinical, pathological and prognostic relationships were analyzed.Results. The plasma CXCL16 levels in IgAN patients were significantly correlated with the uric acid and estimated glomerular filtration rate by both univariate and multivariate analysis. Tubular atrophy/interstitial fibrosis score was still significantly correlated with the plasma CXL16 levels even after adjustment for other potential predictor variables by multivariate analysis. In addition, the counts of CD4+ T cells, CD8+ T cells and CD20+ B cells in renal biopsies of IgAN patients were significantly correlated with the plasma CXCL16 levels, but not CD68+ macrophage. Finally, we concluded that patients with higher plasma CXCL16 levels had higher risk of poor renal outcome compared with those with lower plasma CXCL16 levels. No association was observed between the CXCL16 polymorphisms and clinical parameters including plasma CXCL16 levels and prognosis. Human kidney cells (HK2) expression of CXCL16 was up-regulated by interferon-γ (IFN-γ) via p65 pathway and recombinant CXCL16 promoted the chemotaxis of Jurkat T cells.Conclusions: Plasma CXCL16 levels were associated with creatinine level, 24-urine protein, tubular atrophy/interstitial fibrosis pathological damage, the CD4+ T cells, CD8+ T cells and CD20+ B cells infiltration in renal tissue and renal outcome in IgAN patients. Plasma CXCL16 might be a potential prognosis novel predictor in Chinese patients with IgAN.Funding: This work was financially supported by the Major Research Plan of the National Natural Science Foundation of China (Grant No. 91742204); International (regional) cooperation and exchange projects, (NSFC-DFG, Grant No. 81761138041), National Natural Science Foundation of China (Grants 81470948, 81670633, 81570667), National key research and development program (Grants 2016YFC0906103) and The National Key Technology R&D Program (Grant 2013BAI09B06, 2015BAI12B07). Declaration of Interest: We declare no competing interests.Ethical Approval: This study conformed with the Declaration of Helsinki and approved by the Huazhong University of Science and Technology, Tongji Hospital Ethics Committee on Human Experimentation. Written informed consent was obtained from each patient.

Integrated Proteomics and Metabolomics to Study IgA Nephropathy on Early Stage and Identification of Biomarkers

LC-MS/MS based metabolomics and proteomics reveal candidate biomarkers and molecular mechanism of early IgA nephropathy

Urinary Proteome Analysis by Matrix-Assisted Laser Desorption/Ionization Time-Of-Flight Mass Spectrometry with Magnetic Beads for Identifying the Pathologic Presentation of Clinical Early Iga Nephropathy

Serum Proteomic Analysis by Nanoflow LC-MS/MS-Based Proteomics in IgA Chronic Kidney Disease

Metabolomics study reveals blood biomarkers for early diagnosis of chronic kidney disease and IgA nephropathy: A retrospective cross-sectional study

Unveiling biomarkers and therapeutic targets in IgA nephropathy through large-scale blood transcriptome analysis

Identifying potential biomarkers for the diagnosis and treatment of IgA nephropathy based on bioinformatics analysis

Identification of the Pathologic Presentation of Clinical Early IgA Nephropathy by MALDI-TOF-MS with Magnetic Beads

Establishment and validation of diagnostic model in immunoglobulin A nephropathy based on weighted gene co-expression network analysis

Preliminary Investigation of the Biomarkers of Acute Renal Transplant Rejection Using Integrated Proteomics Studies, Gene Expression Omnibus Datasets, and RNA Sequencing.

Functional networks of aging markers in the glomeruli of IgA nephropathy: a new therapeutic opportunity.

An enhanced machine learning approach for effective prediction of IgA nephropathy patients with severe proteinuria based on clinical data

Altered Serum Metabolic Profile in Patients with IgA Nephropathy.

Identification of a Novel Interplay Between Intestinal Bacteria and Metabolites in Chinese Patients with IgA Nephropathy Via Integrated Microbiome and Metabolome Approaches

Diagnostic Potential of Plasma IgA1 O-Glycans in Discriminating IgA Nephropathy From Other Glomerular Diseases and Healthy Participants

Development of monoclonal antibodies and antigens as liquid biopsy reagents for IgA nephropathy

Plasma CXCL16 May Predict Renal Inflammation and the Progression of Immunoglobulin a Nephropathy

Machine learning-based diagnosis and prognosis of IgAN: A systematic review and meta-analysis

Diagnosis and activity assessment of immunoglobulin A nephropathy: current perspectives on noninvasive testing with aberrantly glycosylated immunoglobulin A-related biomarkers

Proteomic profiling of IgA nephropathy reveals distinct molecular prognostic subtypes

Microbiome and metabolome analysis to clarify the interaction between the urine microbiota and serum metabolites in Chinese patients with immunoglobulin A nephropathy